Anke Mueller-Fahrnow was head of Lead Discovery Berlin within Bayer AG, where she was responsible for Protein Technologies, Structural Biology and for High Throughput Screening. She is now Vice President, Senior Scientific Advisor at Innovation Campus Berlin, Nuvisan. Her research activities are mainly focused on oncology and gynecological therapies. Since July, Anke is the chair of SGC board of directors.